Shaofang Xie
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 1
-
- Immune Cell Function and Interaction 2
- Phagocytosis and Immune Regulation 2
-
- Extracellular vesicles in disease 2
- Pluripotent Stem Cells Research 1
-
- Cancer Immunotherapy and Biomarkers 2
-
- 3D Printing in Biomedical Research 2
-
- Ocular Infections and Treatments 1
- Co-authors
- Xu LiWeixiang BianAifu LinYouhua XieTingting ZhengShibo JiangWei XuYingnan Hou
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nano Letters (1 paper)Immunity (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Shaofang Xie
13 papers receiving 554 citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Infectious Diseases 260
- Cancer Research 78
- Immunology 106
- Neurology 49
- Molecular Biology 205
Countries citing papers authored by Shaofang Xie
This map shows the geographic impact of Shaofang Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaofang Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaofang Xie more than expected).
Fields of papers citing papers by Shaofang Xie
This network shows the impact of papers produced by Shaofang Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaofang Xie. The network helps show where Shaofang Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shaofang Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 20 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 38 | |
| 8 | 2022 | 44 | |
| 9 | AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cellsbreakdown → | 2021 | 334 |
| 10 | 2021 | 40 | |
| 11 | 2019 | 40 | |
| 12 | 2017 | 10 | |
| 13 | 2009 | 9 |
About Shaofang Xie
Shaofang Xie is a scholar working on Immunology, Oncology and Microbiology, having authored 13 papers that have together received 557 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune Cell Function and Interaction (2 papers), Phagocytosis and Immune Regulation (2 papers), 3D Printing in Biomedical Research (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), Ocular Infections and Treatments (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Infectious Diseases (260 citations), Cancer Research (78 citations) and Immunology (106 citations). Shaofang Xie has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xu Li, Weixiang Bian, Aifu Lin, Youhua Xie, Tingting Zheng, Shibo Jiang, Wei Xu, Yingnan Hou, Qiang Zhou and Chong Zhang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nano Letters and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.